You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • OP0075 Impact of Different Infliximab Dose Regimens on Treatment Response and Drug Survival in 462 Patients with PSA. Results from the Nationwide Registries Danbio and Icebio

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Oral Presentations. Abstract session: Genes, disease activity and treatment of psoriatic arthritis
OP0075 Impact of Different Infliximab Dose Regimens on Treatment Response and Drug Survival in 462 Patients with PSA. Results from the Nationwide Registries Danbio and Icebio

 

Online download statistics by month:

Online download statistics by month: June 2014 to March 2024

AbstractFullPdf
Jun 20141001
Jul 2014300
Aug 20141301
Sep 2014701
Oct 20141503
Nov 2014301
Dec 2014601
Jan 2015601
Feb 2015201
Mar 2015601
Apr 2015201
Jun 2015100
Jul 2015200
Aug 2015600
Sep 2015500
Oct 2015200
Nov 2015100
Dec 20151001
Jan 2016100
Feb 2016200
Mar 2016300
Apr 2016300
May 2016200
Jun 2016300
Jul 2016800
Aug 2016300
Sep 2016400
Oct 2016300
Nov 2016601
Dec 2016600
Jan 2017500
Feb 2017900
Mar 2017400
Apr 2017400
May 20171000
Jun 2017901
Jul 2017600
Aug 2017400
Sep 2017600
Oct 2017200
Nov 2017400
Dec 2017800
Jan 20181000
Feb 2018200
Mar 20181400
Apr 2018800
May 20181401
Jun 20181602
Jul 20181000
Aug 2018600
Sep 20181200
Oct 2018601
Nov 2018200
Jan 2019200
Feb 2019600
Mar 2019200
Apr 2019200
May 2019200
Aug 2019100
Jan 2020200
Feb 2020400
May 20201200
Jul 2020200
Sep 2020800
Oct 2020200
Nov 2020200
Dec 2020200
Feb 2021400
Oct 2021601
Nov 2021600
Dec 2021800
Feb 2022200
Mar 2022800
Apr 2022800
May 20221000
Jun 2022400
Jul 20221800
Aug 2022800
Sep 2022200
Oct 2022200
Nov 2022800
Dec 2022600
Jan 2023200
Feb 2023400
Mar 2023300
Apr 2023600
May 2023400
Jun 2023100
Jul 2023200
Aug 2023400
Sep 2023600
Nov 2023200
Dec 2023400
Mar 2024200
Total504020